Skip to main content
. 2024 Apr 25;13(3):663–678. doi: 10.1007/s40122-024-00596-4

Table 2.

Correlations

Correlations p
Volume of solution spread spatium parapharyngeum and retropharyngeum/pain relief 0.025*
Volume of solution spread/spread in spatium parapharyngeum and retropharyngeum 0.0088*
Volume of solution spread/change in NRS 0.0014*
Swelling of pharyngeal wall/post-procedural NRS 0.41
Swelling of pharyngeal wall/volume of solution spread 0.37
Pain reduction/number of GLOA 0.027*
Different approach/postprocedural NRS 0.33
Lateral approach/volume of solution spread 0.11
Patient satisfaction/low post-procedural NRS 0.086
Patient satisfaction/volume of solution spread 0.11
Quality of life/sleep quality 0.28
PSQI GLOA 1 vs. 5 0.625
EQ-5L-5D GLOA 1 vs. 5 0.375
ZUF8 GLOA 1 vs. 5 0.5
Mean NRS V1 vs. FU2 0.022*
Mean EQ-5L-5D V1 vs. FU2 0.088
Mean ZUF8 V1 vs. FU2 0.13
Mean PSQI V1 vs. FU2 0.027*

EQ-5L-5D European Quality of Life 5 Dimensions 5 Level Version, FU2 follow-up 2, GLOA ganglionic local opioid analgesia, NRS Numerical Rating Scale, PSQI Pittsburgh Sleep Quality Index, V1 visit 1, ZU8 Fragebogen zur Messung der Patientenzufriedenheit

*Correlation is significant at p-value < 0.05